Vident Advisory’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$339K Buy
14,180
+3,088
+28% +$75.5K ﹤0.01% 1444
2025
Q4
$251K Sell
11,092
-5,869
-35% -$128K ﹤0.01% 1454
2025
Q3
$342K Buy
16,961
+9
+0.1% +$151 ﹤0.01% 1348
2025
Q2
$242K Buy
16,952
+2,144
+14% +$25.1K ﹤0.01% 1406
2025
Q1
$155K Buy
14,808
+4,698
+46% +$53.1K ﹤0.01% 1474
2024
Q4
$122K Buy
+10,110
New +$132K ﹤0.01% 1395

Other funds holding ELAN

Vident Advisory's ELAN Position: Q1 2026 in Review

Vident Advisory increased its Elanco Animal Health (ELAN) stake by 28% in Q1 2026, buying an estimated $75.5K and bringing the position to 14,180 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #1444.

Vident Advisory first reported a position in ELAN in Q4 2024 and has held it in 6 quarters since. The position peaked at $342K in Q3 2025. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Vident Advisory held 14,180 shares of Elanco Animal Health worth $339K as of Q1 2026.
  • Vident Advisory bought 3,088 Elanco Animal Health shares in Q1 2026, an estimated $75.5K.
  • Elanco Animal Health made up ﹤0.01% of Vident Advisory's portfolio in Q1 2026, its #1444 holding.
  • Vident Advisory first reported a position in Elanco Animal Health in Q4 2024 and has held it in 6 quarters since.
  • Vident Advisory's Elanco Animal Health position peaked at $342K in Q3 2025.
  • 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.